JMPWA
FATE icon

JP Morgan Private Wealth Advisors’s Fate Therapeutics FATE Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$281K Sell
132,334
-3,000
-2% -$9.94K ﹤0.01% 1508
2023
Q2 		$644K Sell
135,334
-2,057
-1% -$11.4K ﹤0.01% 932
2023
Q1 		$783K Buy
137,391
+121,521
+766% +$733K ﹤0.01% 1280
2022
Q4 		$160K Sell
15,870
-10
-0.1% -$188 ﹤0.01% 1847
2022
Q3 		$356K Sell
15,880
-193
-1% -$5.58K ﹤0.01% 1588
2022
Q2 		$398K Sell
16,073
-530
-3% -$14.6K ﹤0.01% 1540
2022
Q1 		$644K Sell
16,603
-1,962
-11% -$76K ﹤0.01% 1415
2021
Q4 		$1.09M Buy
18,565
+291
+2% +$16.5K ﹤0.01% 1202
2021
Q3 		$1.08M Sell
18,274
-1,260
-6% -$98.8K ﹤0.01% 1176
2021
Q2 		$1.7M Sell
19,534
-312
-2% -$25.1K ﹤0.01% 945
2021
Q1 		$1.64M Sell
19,846
-534
-3% -$51.2K 0.01% 836
2020
Q4 		$1.85M Buy
20,380
+1,401
+7% +$87K 0.01% 764
2020
Q3 		$759K Buy
18,979
+8,967
+90% +$313K ﹤0.01% 997
2020
Q2 		$344K Sell
10,012
-5,580
-36% -$166K ﹤0.01% 1249
2020
Q1 		$346K Hold
15,592
– – ﹤0.01% 1078
2019
Q4 		$305K Buy
15,592
+2,360
+18% +$37.5K ﹤0.01% 1233
2019
Q3 		$205K Sell
13,232
-24,400
-65% -$468K ﹤0.01% 1344
2019
Q2 		$764K Hold
37,632
– – ﹤0.01% 841
2019
Q1 		$661K Hold
37,632
– – ﹤0.01% 927
2018
Q4 		$483K Buy
+37,632
New +$525K ﹤0.01% 985

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Private Wealth Advisors's FATE Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its Fate Therapeutics (FATE) stake by 2.2% in Q3 2023, selling an estimated $9.94K and leaving 132,334 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

JP Morgan Private Wealth Advisors first reported a position in FATE in Q4 2018 and has held it in 20 quarters since. The position peaked at $1.85M in Q4 2020. 170 funds tracked by Wall St. Rank hold FATE as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 132,334 shares of Fate Therapeutics worth $281K as of Q3 2023.
  • JP Morgan Private Wealth Advisors sold 3,000 Fate Therapeutics shares in Q3 2023, an estimated $9.94K.
  • Fate Therapeutics made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1508 holding.
  • JP Morgan Private Wealth Advisors first reported a position in Fate Therapeutics in Q4 2018 and has held it in 20 quarters since.
  • JP Morgan Private Wealth Advisors's Fate Therapeutics position peaked at $1.85M in Q4 2020.
  • 170 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.